on 17 Dec 2024
Last Applicant/ Owned by
201 Brookline Ave, Suite 902
Boston
MA
02215
Serial Number
98328101 filed on 22nd Dec 2023
Registration Number
N/A
Correspondent Address
Douglas R. Wolf
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Biomedical research and development services; drug discovery in the field of biologics biopharmaceuticals for cancer, neurological, metabolic, endocrine, gastrointestinal, respiratory, and autoimmune diseases, disorders, and conditions; biopharmaceutical preparations for prevention and treatment of cancer and neurological diseases, disorders, and conditions; biopharmaceutical preparations for pre Read More
Biomedical research and development services; drug discovery in the field of biologics
N/A
N/A
biopharmaceuticals for cancer, neurological, metabolic, endocrine, gastrointestinal, respiratory, and autoimmune diseases, disorders, and conditions; biopharmaceutical preparations for prevention and treatment of cancer and neurological diseases, disorders, and conditions; biopharmaceutical preparations for prevention and treatment of, metabolic, endocrine, gastrointestinal, respiratory, and autoimmune diseases, disorders, and conditions
N/A
N/A
No 98328101
No Service Mark
No M16572000000
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
17th Dec 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
17th Dec 2024 | PUBLISHED FOR OPPOSITION |
11th Dec 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
20th Nov 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
23rd Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
23rd Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
23rd Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
23rd Jul 2024 | ASSIGNED TO EXAMINER |
23rd Jul 2024 | NON-FINAL ACTION E-MAILED |
23rd Jul 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |